glp 1 cigna will stop covering GLP-1 weight-loss drugs including Wegovy and Zepbound in its ​employee health plan effective July 1, according to Reuters Cigna reaches new deal on

Longevity icon Bryan Johnsons methods may be a bust

Our approach to the treatment of obesity in older adults should be inherently different, given that they have different medical needs and goals

La direccin web del sitio no se corresponde con el portal digital del peridico (www.elmundo.es)

Cardiovascular Outcomes Trial in Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease Trial 8 [Peptide Innovation for Early Diabetes Treatment (PIONEER 6), NCT02692716] was a multi-center, multi-national, placebo-controlled, double-blind trial

Bismuth subsalicylate (Pepto-Bismol) is particularly useful for this combination, as it addresses both the sulfur burps and the diarrhea simultaneously

All claims are grounded in verifiable data up to 2026